Hyperfine, Inc. (HYPR) vs Zomedica Corp. (ZOMDF)
Hyperfine, Inc. and Zomedica Corp. are both Medical Devices companies. Zomedica Corp. is the larger, with a market value of $95.4M against $84.4M — 1.1× the size. Hyperfine, Inc. grew revenue faster over the last twelve months: 53.2% against 30.1%. Zomedica Corp. has the higher net margin (−51.4% vs −210.8%) and the higher return on invested capital (−20.5% vs −401.8%). Across the 17 metrics below, Zomedica Corp. leads on 15 and Hyperfine, Inc. on 2.
Valuation
Profitability
| Metric | HYPR | ZOMDF | Medical Devices median |
|---|---|---|---|
| Gross margin | 51.41% | 65.44% | 56.01% |
| Operating margin | (203.27%) | (56.28%) | (15.03%) |
| Net margin | (210.75%) | (51.39%) | (20.40%) |
| Free cash flow margin | (166.48%) | (40.75%) | (7.24%) |
| Return on equity | (96.97%) | (16.29%) | (15.32%) |
| Return on assets | (64.40%) | (14.88%) | (19.72%) |
| Return on invested capital | (401.79%) | (20.54%) | (10.33%) |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack